Development and implementation of optimized endogenous contrast sequences for delineation in adaptive radiotherapy on a 1.5T MR-linear-accelerator: a prospective R-IDEAL stage 0-2a quantitative/qualitative evaluation of <i>in vivo</i> site-specific quality-assurance using a 3D T2 fat-suppressed platform for head and neck cancer.

J Med Imaging (Bellingham) · 2023 · PMC10627232 · PMID 37937259

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

narrowly missed significancep = 0.08so close (0.05 < p ≤ 0.1)

SPAIR 1 and 3 received significantly higher median grades than the nonsuppressed sequence (SPAIR 4 versus Non-FS narrowly missed significance with p = 0.08 ).

also in 39 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.